Equity Overview
Price & Market Data
Price: $21.89
Daily Change: -$0.55 / 2.51%
Range: $21.31 - $22.75
Market Cap: $408,741,024
Volume: 155,838
Performance Metrics
1 Week: -5.07%
1 Month: 10.00%
3 Months: -14.59%
6 Months: -54.83%
1 Year: 22.43%
YTD: -52.59%
Company Details
Employees: 51
Sector: Commercial services
Industry: Miscellaneous commercial services
Country: United States
Details
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.